René Bruno
172 works · 5,964 citations · h-index 39
Top works
- Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
- Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.
- A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validation
- Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer
- Population Pharmacokinetics of Rituximab (Anti‐CD20 Monoclonal Antibody) in Rheumatoid Arthritis Patients During a Phase II Clinical Trial
- Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer
- Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
- The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.
- Pharmacokinetics and metabolism of Taxotere (docetaxel).
- Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.
- Evaluation of Tumor-Size Response Metrics to Predict Overall Survival in Western and Chinese Patients With First-Line Metastatic Colorectal Cancer
- Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation
- Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
- Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma
- Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
- Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: Application to pefloxacin in intensive care unit patients
- Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.